Camptothecin in Cancer Therapy: Current Challenges and Emerging Strategies with Nanoemulsions
Pharmaceutics
Heber Uriel Pérez-Ortega
División de Estudios de Posgrado e Investigación (DEPI), Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico
Rubén Ricardo Córdova-EspírituORCID
Departamento de Ingeniería Bioquímica y Ambiental, Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico
Sebastian Cano-Serrano
División de Estudios de Posgrado e Investigación (DEPI), Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico
Eduardo García-González
Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Roque (ITR), Celaya 38110, Guanajuato, Mexico; Programa de Ingeniería en Biotecnología, Campus Celaya-Salvatierra, Universidad de Guanajuato, Mutualismo #303, Col. La Suiza, Celaya 36060, Guanajuato, Mexico
Micael Gerardo Bravo-SánchezORCID
Departamento de Ingeniería Bioquímica y Ambiental, Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico
Ma. del Carmen Orozco-MosquedaORCID
Departamento de Ingeniería Bioquímica y Ambiental, Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico
Hugo Jiménez-IslasORCID
Departamento de Ingeniería Bioquímica y Ambiental, Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico
Gabriel Luna-BárcenasORCID
Tecnológico de Monterrey, Instituto de Materiales Avanzados para una Manufactura Sostenible, Epigmenio González 500 Fracc. San Pablo, Querétaro 76130, Querétaro, Mexico
Francisco Villaseñor-OrtegaORCID
Departamento de Ingeniería Bioquímica y Ambiental, Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico
Camptothecin (CPT) is a natural alkaloid with potent antiproliferative activity, mediated by the inhibition of Topoisomerase I (Topo I), an essential enzyme for deoxyribonucleic acid (DNA) replication. However, its clinical application has been limited by low solubility and the instability of the lactone ring under physiological conditions, both of which decrease its efficacy. Semi-synthetic analogs such as irinotecan (CPT-11) and topotecan (TPT) have been developed and approved for the treatment of various types of cancer; however, challenges related to drug resistance and side effects continue to arise. Therefore, nanomedicine and nanoparticle-based delivery systems, including nanoemulsions, liposomes, and antibody–drug conjugates (ADCs), emerge as promising strategies to improve the stability, bioavailability, and effectiveness of CPT, despite significant challenges such as scalability, pharmacokinetic variability, and regulatory requirements. This review discusses recent advances in CPT, its analogs, and these delivery platforms, highlighting its potential to optimize cancer therapy and reduce toxicity while outlining translational challenges such as scalability, pharmacokinetic variability, and regulatory requirements.
Comprueba el estilo que requiere tu institución o revista.
Heber Uriel Pérez-Ortega; Rubén Ricardo Córdova-Espíritu; Sebastian Cano-Serrano; Eduardo García-González; Micael Gerardo Bravo-Sánchez; Ma. del Carmen Orozco-Mosqueda; Hugo Jiménez-Islas; Gabriel Luna-Bárcenas; Francisco Villaseñor-Ortega. (2025). Camptothecin in Cancer Therapy: Current Challenges and Emerging Strategies with Nanoemulsions. Pharmaceutics, 17(11), 1414. https://doi.org/10.3390/pharmaceutics17111414
Fuentes y trazabilidad
Se conserva la procedencia de los datos y se da prioridad a la revista cuando existe información editorial.